Carl Hull is retiring as Executive Chairman of Maravai Lifesciences, effective December 5, 2024, and Robert Andrew Eckert has been appointed as his successor, with a cash retainer of $175,000 and RSU awards valued at $750,000 and $500,000.
AI Assistant
MARAVAI LIFESCIENCES HOLDINGS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.